Target: Robert Califf, Commissioner of U.S. Food & Drug Administration
Goal: Support continuation of drugs increasingly essential for maintaining patients’ reproductive rights.
The latest battle against reproductive rights has focused on women’s abilities to access a pill that helps end pregnancy. This ForceChange petition outlined some of the ramifications of a potential prohibition of the drug Mifepristone. And when a group of physicians challenged the very right of America’s top drug regulatory agency to approve the drug, they likely expected a favorable ruling from a sympathetic majority of the Supreme Court. They were wrong.
In a unanimous decision, the Supreme Court tossed out the complaint and upheld the Federal Drug Administration’s (FDA) decades-long approval and regulatory dispensing of Mifepristone. The ruling was welcomed by major medical associations and by advocates who had previously seen reproductive rights decimated. In addition, the ruling serves as a potential cautionary tale for the increasing number of lobbyists who “shop” for judges and courts they believe will rule in their favor. And the ruling further strikes a blow to efforts of many of the same lobbyists to deregulate issues related to consumer and medical protection.
Sign the petition below to thank the agency who fought for – and preserved – crucial consumer rights.
PETITION LETTER:
Dear Dr. Califf,
Congratulations on your success in the federal case brought by physicians who challenged both reproductive rights and your ability to conduct your job. The Food and Drug Administration is considered a gold standard in regulation and protection for a reason. This agency has tirelessly worked to ensure that Mifepristone and similar pharmaceuticals are safe and beneficial for consumers.
Thank you for taking a stand and holding your ground.
Sincerely,
[Your Name Here]
Photo Credit: Lorie Shaull
